Haemonetics
HAE
$88.13
Share price
1.80%
Change (1 day)
35.07%
Change (1 year)
Categories
Revenue for Haemonetics (HAE)
Revenue in 2023 (TTM): $1.16 B
According to Haemonetics's latest financial reports the company's current revenue (TTM) is $1.16 B. In 2022 the company made a revenue of $1.12 B an increase over the years 2021 revenue that were of $0.95 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Haemonetics from 2001 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $1.16 B | 3.49% |
| 2022 | $1.12 B | 18.47% |
| 2021 | $0.95 B | 7.84% |
| 2020 | $0.88 B | -11.54% |
| 2019 | $0.99 B | 4.98% |
| 2018 | $0.95 B | 5.94% |
| 2017 | $0.89 B | -0.31% |
| 2016 | $0.90 B | 0.93% |
| 2015 | $0.89 B | -3.46% |
| 2014 | $0.92 B | -2.36% |
| 2013 | $0.94 B | 14.32% |
| 2012 | $0.82 B | 16.52% |
| 2011 | $0.71 B | 5.24% |
| 2010 | $0.67 B | 7.48% |
| 2009 | $0.62 B | 7.62% |
| 2008 | $0.58 B | 18.11% |
| 2007 | $0.49 B | 11.63% |
| 2006 | $0.44 B | 8.25% |
| 2005 | $0.40 B | 7.33% |
| 2004 | $0.38 B | 9.77% |
| 2003 | $0.34 B | 3.66% |
| 2002 | $0.33 B | 5.18% |
| 2001 | $0.31 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $96.26 B | 8,137.04% | 🇺🇸 USA |
 Medtronic MDT | $30.77 B | 2,533.10% | 🇮🇪 Ireland |
 Thermo Fisher Scientific TMO | $43.80 B | 3,648.48% | 🇺🇸 USA |
 Baxter BAX | $15.05 B | 1,188.23% | 🇺🇸 USA |
 Becton Dickinson BDX | $18.80 B | 1,509.45% | 🇺🇸 USA |
 Stryker Corporation SYK | $18.95 B | 1,521.69% | 🇺🇸 USA |
 PerkinElmer
PKI | $3.35 B | 187.29% | 🇺🇸 USA |
 Cerus CERS | $0.15 B | -86.69% | 🇺🇸 USA |